Health Care · Health Care Equipment
Insulet: revenue, profit and cash flow
In fiscal 2025, Insulet had revenue of $2.71B, up 26.2% a year on average since 2015, and net income of $247M (9.1% of revenue). It has 27% more shares than in 2015.
Revenue, fiscal 2025
average annual revenue growth since 2015 · +30.7% vs 2024
- Ticker
- PODD · Nasdaq
- Sector
- Health Care
- Sub-industry
- Health Care Equipment
- Headquarters
- Acton, Massachusetts
- Founded
- 2000
- In the S&P 500 since
- March 15, 2023
- Latest fiscal year
- 2025, ended December 31, 2025
- SEC filer
- Insulet Corp · CIK 0001145197
Revenue and net income
Revenue went from $66M in 2009 to $2.71B in 2025. Net loss in 2009–2017.
Diluted earnings per share
Diluted EPS went from −$2.43 in 2009 to $3.48 in 2025.
Shares outstanding
26.6% more shares in 2025 than in 2015 (56.8M → 71.9M): new shares outweighed buybacks.
Operating cash flow, capex and free cash flow
Free cash flow (operating cash flow minus capital expenditure) was $378M in 2025, 13.9% of revenue. Negative in 2009–2022.
The chart data could not be loaded. The table below has the same figures.
Year by year
| Fiscal year | Revenue | Net income | Net margin | Diluted EPS | Shares | Operating cash flow | Capex | Free cash flow |
|---|---|---|---|---|---|---|---|---|
| 2025 | $2.71B | $247M | 9.1% | $3.48 | 71.9M | $569M | $192M | $378M |
| 2024 | $2.07B | $418M | 20.2% | $5.78 | 73.9M | $430M | $125M | $305M |
| 2023 | $1.7B | $206M | 12.2% | $2.94 | 73.6M | $146M | $75.6M | $70.1M |
| 2022 | $1.31B | $4.6M | 0.4% | $0.07 | 69.9M | $119M | $123M | −$3.9M |
| 2021 | $1.1B | $16.8M | 1.5% | $0.24 | 68.6M | −$68.1M | $112M | −$180M |
| 2020 | $904M | $6.8M | 0.8% | $0.10 | 65.9M | $84M | $129M | −$45M |
| 2019 | $738M | $11.6M | 1.6% | $0.19 | 62.3M | $98.4M | $164M | −$65.3M |
| 2018 | $564M | $3.3M | 0.6% | $0.05 | 61M | $35.9M | $157M | −$122M |
| 2017 | $464M | −$26.8M | −5.8% | −$0.46 | 58M | $41.3M | $73.8M | −$32.5M |
| 2016 | $367M | −$28.9M | −7.9% | −$0.48 | 57.3M | $15.9M | $22.1M | −$6.2M |
| 2015 | $264M | −$73.5M | −27.9% | −$1.29 | 56.8M | −$12.6M | $10.6M | −$23.2M |
| 2014 | $231M | −$51.5M | −22.3% | −$0.93 | 55.6M | $8.92M | $11.5M | −$2.57M |
| 2013 | $247M | −$45M | −18.2% | −$0.83 | 54M | $3.35M | $7.31M | −$3.96M |
| 2012 | $211M | −$51.9M | −24.5% | −$1.08 | 47.9M | −$29.1M | $11M | −$40M |
| 2011 | $152M | −$45.8M | −30.1% | −$0.98 | 46.7M | −$25.5M | $11.1M | −$36.6M |
| 2010 | $97M | −$61.2M | −63.1% | −$1.54 | 39.6M | −$35.6M | $6.55M | −$42.2M |
| 2009 | $66M | −$72.3M | −109.6% | −$2.43 | — | −$49.3M | $3.14M | −$52.5M |
Fiscal years, labelled by the year in which they end. US dollars; per-share figures and share counts adjusted for splits. —: not in the data.
About these figures
- No dividends per share in the filings data. Usually that means no dividend, but some companies report theirs in a form the data do not capture.
- Older years are as filed at the time and may predate later restatements, mergers or spin-offs. How the figures are made.
Other Health Care Equipment companies
Source: SEC EDGAR (company filings), data as of November 8, 2026. Sectors, sub-industries, headquarters and index dates: Wikipedia, CC BY-SA 4.0.